Network Insights Methodology Whitepaper Get Access

Pfizer

ORG Health Care / Pharmaceuticals Momentum 11.3ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. CRITICALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$60B+ revenue (2025), New York pharma giant advancing monthly obesity drug with demonstrated efficacy in diabetes and weight management. Clinical data presented at ADA26 shows continued potential as competitor to GLP-1 market leaders.

Active development and clinical advancement of monthly injectable obesity and diabetes treatment, positioning for competitive market entry against Novo Nordisk and Eli Lilly.
0.01
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
11.3
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
11
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Pfizer is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Merck Novartis FDA AstraZeneca Roche CEO PlocamiumAI NYSE London AMD S&P 500 China Nevada Nvidia White House
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-18 2026-06-17 12 0 Degree Mentions
Signal Decomposition
Attention Cascade
3.333
Narrative Drift
0.000
Spectral Shift
429.102
Sentiment-Momentum Divergence
0.000
Source Concentration
0.820
Signal
Pfizer is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #35 of 87 in Health Care — in line with sector peers. PSI stable vs yesterday (-0.06).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
35 of 87
Sector Rank
+0.25
Peer Z-Score
60%
Sector Percentile
Network Analysis
11 Degree Centrality
Ego Network (top connections)
Merck (weight 94.0)Novartis (weight 92.0)FDA (weight 14.0)AstraZeneca (weight 6.0)Roche (weight 4.0)CEO (weight 4.0)PlocamiumAI (weight 4.0)NYSE (weight 4.0) MerckNovartisFDAAstraZenecaRocheCEOPlocamiumAINYSE Pfizer (degree 11) Pfizer
Centrality History
2026-05-18 2026-06-17 12 0 Degree Mentions
EntityWeight StatusFirst Seen
Merck 94 STRENGTHENED
Novartis 92 NEW
FDA 14 STABLE
AstraZeneca 6 NEW
Roche 4 NEW
CEO 4 STABLE
PlocamiumAI 4 NEW
NYSE 4 STRENGTHENED
London 3 STABLE
AMD 3 NEW
S&P 500 3 NEW
China 3 STABLE
Nevada 2 NEW
Nvidia 2 STABLE
White House 2 STABLE
Alphabet 2 STABLE
Walmart 2 NEW
WHO 2 STABLE
Middle East 2 STABLE
Eli Lilly 1 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-06-17 ← Intelligence Network